EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Beyond seizures in Dravet and Lennox–Gastaut syndromes − An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine

Giancarlo Di Gennaro, Domenica Immacolata Battaglia, Paolo Bonanni, Antonietta Coppola, Edoardo Ferlazzo, Antonio Gambardella, Claudio Liguori, Tullio Messana, Dario Pruna, Gaetano Terrone, Marina Trivisano, Carlo Di Bonaventura

Epilepsy & Behavior · 2026-11 · 184 · 111244

DOI: 10.1016/j.yebeh.2026.111244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026-11. Verfasst von Giancarlo Di Gennaro und 11 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Neuromed, Pozzilli, Italy. Electronic address: gdigennaro@neuromed.it. Hauptthemen laut MEDLINE: Fenfluramine, Lennox Gastaut Syndrome, Seizures, Epilepsies, Myoclonic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Union Chimique Belge.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) are rare developmental and epileptic encephalopathies (DEEs) in which disability and family burden are driven by seizures and non-seizure issues (NSIs), including cognition, behavior, sleep, communication, motor function, and adaptive abilities. OBJECTIVE: To develop practical consensus statements on NSIs in DS and LGS, integrating NSI evaluation within a DEE framework and appraising the perceived role of fenfluramine (FFA). METHODS: An Italian panel of 12 epilepsy specialists spanning pediatric and adult practice developed statements using an Estimate-Talk-Estimate process. Consensus was predefined as ≥ 70% agreement (agree/strongly agree). RESULTS: Eleven final statements were clustered into three macro-areas, with the first two explored in greater depth: (1) the cross-cutting, lifespan impact of NSIs in DS and LGS; (2) the potential for FFA to provide clinically meaningful benefits across selected NSI domains in DS and, more variably, in LGS, with effects not always fully captured by seizure metrics; and (3) the role of other interventions on NSIs and the need for structured assessment tools. CONCLUSIONS: Incorporating NSI priorities into shared goal-setting and longitudinal monitoring may improve the clinical relevance of care in DS and LGS. The panel supported an NSI-informed, net-benefit approach to treatment optimization and identified FFA as a relevant option, while recognizing that evidence on NSI outcomes remains heterogeneous and should be strengthened through syndrome-specific, longitudinal assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenfluramineLennox Gastaut SyndromeSeizuresEpilepsies, MyoclonicHumansItalyAnticonvulsants

Stichwörter der Autor:innen

Adaptive behaviorCaregiver burdenDravet syndromeExecutive functionFenfluramineLennox–Gastaut syndromeNon‑seizure issues

Substanzen

FenfluramineAnticonvulsants

Autor:innen und Institutionen

  • IRCCS Neuromed, Pozzilli, Italy. Electronic address: gdigennaro@neuromed.it.
  • Child Neuropsychiatry Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
  • Scientific Institute IRCCS E. Medea, Epilepsy and Clinical Neurophysiology Unit (UOC), Conegliano, Italy.
  • Neurology Unit and Epilepsy Center, Federico II University Hospital, Naples, Italy.
  • Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Regional Epilepsy Center, "BMM" Great Metropolitan Hospital, Reggio Calabria, Italy.
  • Neurology Unit, Renato Dulbecco University Hospital, Catanzaro, Italy.

Förderung

  • Union Chimique Belge

Zitieren

APA

Di Gennaro, G., Battaglia, D. I., Bonanni, P., Coppola, A., Ferlazzo, E., Gambardella, A., Liguori, C., Messana, T., Pruna, D., Terrone, G., Trivisano, M., & Di Bonaventura, C. (2026). Beyond seizures in Dravet and Lennox–Gastaut syndromes − An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine. Epilepsy & Behavior, 184, 111244. https://doi.org/10.1016/j.yebeh.2026.111244

Vancouver

Di Gennaro G, Battaglia DI, Bonanni P, Coppola A, Ferlazzo E, Gambardella A, et al. Beyond seizures in Dravet and Lennox–Gastaut syndromes − An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine. Epilepsy & Behavior. 2026;184:111244. doi:10.1016/j.yebeh.2026.111244

BibTeX
@article{DiGennaro2026,
  author = {Di Gennaro, Giancarlo and Battaglia, Domenica Immacolata and Bonanni, Paolo and Coppola, Antonietta and Ferlazzo, Edoardo and Gambardella, Antonio and Liguori, Claudio and Messana, Tullio and Pruna, Dario and Terrone, Gaetano and Trivisano, Marina and Di Bonaventura, Carlo},
  title = {Beyond seizures in Dravet and Lennox–Gastaut syndromes − An Italian Expert Consensus on Non-Seizure issues and the role of fenfluramine},
  journal = {Epilepsy & Behavior},
  year = {2026},
  volume = {184},
  pages = {111244},
  doi = {10.1016/j.yebeh.2026.111244}
}
Kostenlos starten →